Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-09-18

Clinical Trial Update: Immunogenicity and Safety of TNFa Kinoid in Rheumatoid Arthritis With Secondary Resistance to TNFa Antagonists [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating immunogenicity and safety of TNF kinoid in rheumatoid arthritis patients with secondary resistance to TNF inhibitors; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TNF-α kinoid (TNF-α kinoid)

Snippet

Sponsor: Neovacs | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED